Primary Job Title Investment Committee Member Primary Organization 
GBS Ventures
Location Melbourne, Victoria, Australia Regions Asia-Pacific (APAC), Australasia Gender Male
LinkedIn View on LinkedIn
Dr Morstyn has extensive experience in drug development and biotechnology. He was head of the clinical program at the Ludwig Institute for Cancer Research in Melbourne and Principal Investigator on the earliest clinical studies of haemopoietic growth factors.
From 1991 to 2002, Dr Morstyn worked for Amgen, rising to Senior Vice President of
Development and Chief Medical Officer in 1999.
Dr Morstyn is Chair of the Board of GBS Bioventures, Deputy Chair of the Victorian Comprehensive Cancer Centre, board member and chair of the scientific advisory board of Symbio (Japan), board member of Proacta, Therapeutic Innovation Australia and a member of the scientific advisory committee of Circadian.
